Logo image of FME.DE

FRESENIUS MEDICAL CARE AG (FME.DE) Stock Price, Forecast & Analysis

Europe - FRA:FME - DE0005785802 - Common Stock

41.76 EUR
+0.59 (+1.43%)
Last: 11/5/2025, 5:36:15 PM

FME.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap24.51B
Revenue(TTM)19.34B
Net Income(TTM)656.42M
Shares586.83M
Float419.26M
52 Week High54.02
52 Week Low39.43
Yearly Dividend1.19
Dividend Yield3.09%
EPS(TTM)3.22
PE12.97
Fwd PE9.89
Earnings (Next)11-04 2025-11-04/bmo
IPO1996-10-02
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services


FME.DE short term performance overview.The bars show the price performance of FME.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

FME.DE long term performance overview.The bars show the price performance of FME.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30

The current stock price of FME.DE is 41.76 EUR. In the past month the price decreased by -10.98%. In the past year, price increased by 3.7%.

FRESENIUS MEDICAL CARE AG / FME Daily stock chart

FME.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
CVS.DE CVS HEALTH CORP 11.43 86.37B
FRE.DE FRESENIUS SE & CO KGAA 14.69 27.06B
V3V.DE FAMICORD AG 37.86 93.49M
HI.MI HEALTH ITALIA SPA 20.33 54.15M

About FME.DE

Company Profile

FME logo image Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 112,445 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.

Company Info

FRESENIUS MEDICAL CARE AG

Else-Kroener-Strasse 1

Bad Homburg vor der Hohe HESSEN DE

Employees: 111513

FME Company Website

FME Investor Relations

Phone: 4961726090

FRESENIUS MEDICAL CARE AG / FME.DE FAQ

What does FME do?

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 112,445 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.


What is the stock price of FRESENIUS MEDICAL CARE AG today?

The current stock price of FME.DE is 41.76 EUR. The price increased by 1.43% in the last trading session.


Does FME stock pay dividends?

FRESENIUS MEDICAL CARE AG (FME.DE) has a dividend yield of 3.09%. The yearly dividend amount is currently 1.19.


How is the ChartMill rating for FRESENIUS MEDICAL CARE AG?

FME.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Can you provide the growth outlook for FRESENIUS MEDICAL CARE AG?

The Revenue of FRESENIUS MEDICAL CARE AG (FME.DE) is expected to grow by 1.28% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Can you provide the number of employees for FRESENIUS MEDICAL CARE AG?

FRESENIUS MEDICAL CARE AG (FME.DE) currently has 111513 employees.


What is FRESENIUS MEDICAL CARE AG worth?

FRESENIUS MEDICAL CARE AG (FME.DE) has a market capitalization of 24.51B EUR. This makes FME.DE a Large Cap stock.


FME.DE Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to FME.DE. When comparing the yearly performance of all stocks, FME.DE is a bad performer in the overall market: 60.94% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

FME.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to FME.DE. FME.DE has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

FME.DE Financial Highlights

Over the last trailing twelve months FME.DE reported a non-GAAP Earnings per Share(EPS) of 3.22. The EPS decreased by -0.08% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.36%
ROA 2.1%
ROE 4.95%
Debt/Equity 0.71
Chartmill High Growth Momentum
EPS Q2Q%-32.02%
Sales Q2Q%4.49%
EPS 1Y (TTM)-0.08%
Revenue 1Y (TTM)-0.61%

FME.DE Forecast & Estimates

25 analysts have analysed FME.DE and the average price target is 49.48 EUR. This implies a price increase of 18.49% is expected in the next year compared to the current price of 41.76.

For the next year, analysts expect an EPS growth of 17.76% and a revenue growth 1.28% for FME.DE


Analysts
Analysts67.2
Price Target49.48 (18.49%)
EPS Next Y17.76%
Revenue Next Year1.28%

FME.DE Ownership

Ownership
Inst Owners43.16%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A